Proinflammatory genotype is associated with the frailty phenotype in the English Longitudinal Study of Ageing

Aging Clinical and Experimental Research

Volumn 28, Issue 3, 2016, Pages 413-421

  Mekli, Krisztina ^a   Nazroo, James Y ^a   Marshall, Alan D ^a   Kumari, Meena ^b,d   Pendleton, Neil ^c  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

^d UNIVERSITY OF ESSEX   (United Kingdom)

Author keywords

Biomarker; Frailty; SNP; TNF

Indexed keywords

BIOLOGICAL MARKER; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; PROTEIN TYROSINE PHOSPHATASE; STEROID HORMONE; TUMOR NECROSIS FACTOR; GENETIC MARKER; PTPRJ PROTEIN, HUMAN; RECEPTOR LIKE PROTEIN TYROSINE PHOSPHATASE;

ADULT; AGED; AGING; ARTICLE; ENDOPHENOTYPE; FEMALE; FRAILTY; GENE LOCUS; GENETIC ASSOCIATION; GENOTYPE; HEALTH STATUS; HUMAN; INFLAMMATION; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; SINGLE NUCLEOTIDE POLYMORPHISM; ANALYSIS; EPIDEMIOLOGY; FRAIL ELDERLY; GENETIC ASSOCIATION STUDY; GENETIC MARKER; GENETICS; GENOTYPE ENVIRONMENT INTERACTION; HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS HYPOPHYSIS SYSTEM; UNITED KINGDOM;

AGED; AGING; ENDOPHENOTYPES; FEMALE; FRAIL ELDERLY; GENE-ENVIRONMENT INTERACTION; GENETIC ASSOCIATION STUDIES; GENETIC MARKERS; GENOTYPE; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; INFLAMMATION; LONGITUDINAL STUDIES; MALE; PITUITARY-ADRENAL SYSTEM; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTOR-LIKE PROTEIN TYROSINE PHOSPHATASES, CLASS 3; TUMOR NECROSIS FACTOR-ALPHA; UNITED KINGDOM;

EID: 84973901075     PISSN: 15940667     EISSN: 17208319     Source Type: Journal    
DOI: 10.1007/s40520-015-0419-z     Document Type: Article

References (44)

1. Clegg A, Young J, Iliffe S et al (2013) Frailty in elderly people. Lancet 381:752–762
2. Carcaillon L, Blanco C, Alonso-Bouzón C et al (2012) Sex differences in the association between serum levels of testosterone and frailty in an elderly population: the Toledo Study for Healthy Aging. PLoS One 7:e32401
3. Baylis D, Bartlett DB, Syddall HE et al (2013). Immune-endocrine biomarkers as predictors of frailty and mortality: a 10-year longitudinal study in community-dwelling older people. Age (Dordrecht, Netherlands) 35:963–971
4. Morley JE, Kaiser FE, Perry HM 3rd et al (1997) Longitudinal changes in testosterone, luteinizing hormone, and follicle-stimulating hormone in healthy older men. Metabolism 46:410–413
5. Lamberts SW, van den Beld AW, van der Lely AJ (1997) The endocrinology of aging. Science 278:419–424
6. Ferrari E, Cravello L, Muzzoni B et al (2001) Age-related changes of the hypothalamic-pituitary-adrenal axis: pathophysiological correlates. Eur J Endocrinol 144:319–329
7. Hofbauer LC, Ten RM, Khosla S (1999) The anti-androgen hydroxyflutamide and androgens inhibit interleukin-6 production by an androgen-responsive human osteoblastic cell line. J Bone Miner Res 14:1330–1337
8. Corcoran MP, Meydani M, Lichtenstein AH et al (2010) Sex hormone modulation of proinflammatory cytokine and C-reactive protein expression in macrophages from older men and postmenopausal women. J Endocrinol 206:217–224
9. Girasole G, Jilka RL, Passeri G et al (1992) 17 beta-estradiol inhibits interleukin-6 production by bone marrow-derived stromal cells and osteoblasts in vitro: a potential mechanism for the antiosteoporotic effect of estrogens. J Clin Investig 89:883–891
10. Straub RH, Konecna L, Hrach S et al (1998) Serum dehydroepiandrosterone (DHEA) and DHEA sulfate are negatively correlated with serum interleukin-6 (IL-6), and DHEA inhibits IL-6 secretion from mononuclear cells in man in vitro: possible link between endocrinosenescence and immunosenescence. J Clin Endocrinol Metab 83:2012–2017
11. De Martinis M, Franceschi C, Monti D et al (2006) Inflammation markers predicting frailty and mortality in the elderly. Exp Mol Pathol 80:219–227
12. Harris TB, Ferrucci L, Tracy RP et al (1999) Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly. Am J Med 106:506–512
13. Reuben DB, Cheh AI, Harris TB et al (2002) Peripheral blood markers of inflammation predict mortality and functional decline in high-functioning community-dwelling older persons. J Am Geriatr Soc 50:638–644
14. Collerton J, Martin-Ruiz C, Davies K et al (2012) Frailty and the role of inflammation, immunosenescence and cellular ageing in the very old: cross-sectional findings from the Newcastle 85+ Study. Mech Ageing Dev 133:456–466
15. Hubbard RE, O’Mahony MS, Savva GM et al (2009) Inflammation and frailty measures in older people. J Cell Mol Med 13:3103–3109
16. Leng S, Chaves P, Koenig K et al (2002) Serum interleukin-6 and hemoglobin as physiological correlates in the geriatric syndrome of frailty: a pilot study. J Am Geriatr Soc 50:1268–1271
17. Walston J, Arking DE, Fallin D et al (2005) IL-6 gene variation is not associated with increased serum levels of IL-6, muscle, weakness, or frailty in older women. Exp Gerontol 40:344–352
18. Almeida OP, Norman PE, van Bockxmeer FM et al (2012) CRP 1846G>A polymorphism increases risk of frailty. Maturitas 71:261–266
19. Ho YY, Matteini AM, Beamer B et al (2011) Exploring biologically relevant pathways in frailty. J Gerontol Ser A Biol Sci Med Sci 66:975–979
20. Fried LP, Tangen CM, Walston J et al (2001) Frailty in older adults: evidence for a phenotype. J Gerontol Ser A Biol Sci Med Sci 56:M146–M156
21. Tajar A, O’Connell MD, Mitnitski AB et al (2011) Frailty in relation to variations in hormone levels of the hypothalamic-pituitary-testicular axis in older men: results from the European male aging study. J Am Geriatr Soc 59:814–821
22. Fishman D, Faulds G, Jeffery R et al (1998) The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Investig 102:1369–1376
23. Wilson AG, Symons JA, McDowell TL et al (1997) Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci USA 94:3195–3199
24. Shin SY, Fauman EB, Petersen AK et al (2014) An atlas of genetic influences on human blood metabolites. Nat Genet 46:543–550
25. Steptoe A, Breeze E, Banks J et al (2013) Cohort profile: the English longitudinal study of ageing. Int J Epidemiol 42:1640–1648
26. Pepys MB, Hirschfield GM (2003) C-reactive protein: a critical update. J Clin Investig 111:1805–1812
27. Sproston K, Mindell J (ed) (2004) Health Survey for England. Methodology and documentation, vol 2, pp 34–41. http://www.hscic.gov.uk/catalogue/PUB01170/hea-surv-ethn-min-eng-2004-rep-v2.pdf
28. Radloff LS (1977) The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas 1:385–401
29. Purcell S, Neale B, Todd-Brown K et al (2007) PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81:559–575
30. Barrett JC, Fry B, Maller J et al (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21:263–265
31. Aggarwal BB (2003) Signalling pathways of the TNF superfamily: a double-edged sword. Nat Rev Immunol 3:745–756
32. Fraunberger P, Pilz G, Cremer P et al (1998) Association of serum tumor necrosis factor levels with decrease of cholesterol during septic shock. Shock 10:359–363
33. Daïen CI, Duny Y, Barnetche T et al (2012) Effect of TNF inhibitors on lipid profile in rheumatoid arthritis: a systematic review with meta-analysis. Ann Rheum Dis 71:862–868
34. Landi F, Russo A, Pahor M et al (2008) Serum high-density lipoprotein cholesterol levels and mortality in frail, community-living elderly. Gerontology 54:71–78
35. Brescianini S, Maggi S, Farchi G et al (2003) Low total cholesterol and increased risk of dying: are low levels clinical warning signs in the elderly? Results from the Italian longitudinal study on aging. J Am Geriatr Soc 51:991–996
36. Teslovich TM, Musunuru K, Smith AV et al (2010) Biological, clinical and population relevance of 95 loci for blood lipids. Nature 466:707–713
37. Ostman A, Hellberg C, Böhmer FD (2006) Protein-tyrosine phosphatases and cancer. Nat Rev Cancer 6:307–320
38. Tangye SG, Phillips JH, Lanier LL et al (1998) CD148: a receptor-type protein tyrosine phosphatase involved in the regulation of human T cell activation. J Immunol 161:3249–3255
39. de Lima VC, de Carvalho AF, Morato-Marques M et al (2013) TNF-alpha and melphalan modulate a specific group of early expressed genes in a murine melanoma model. Cytokine 62:217–225
40. Leng SX, Cappola AR, Andersen RE et al (2004) Serum levels of insulin-like growth factor-I (IGF-I) and dehydroepiandrosterone sulfate (DHEA-S), and their relationships with serum interleukin-6, in the geriatric syndrome of frailty. Aging Clin Exp Res 16:153–157
41. Ambrose M, Gatti RA (2013) Pathogenesis of ataxia-telangiectasia: the next generation of ATM functions. Blood 121:4036–4045
42. Wang K, Ye Y, Xu Z et al (2010) Interaction between BRCA1/BRCA2 and ATM/ATR associate with breast cancer susceptibility in a Chinese Han population. Cancer Genet Cytogenet 200:40–46
43. Gaikwad NW, Yang L, Pruthi S et al (2009) Urine biomarkers of risk in the molecular etiology of breast cancer. Breast Cancer Basic Clin Res 3:1–8
44. Voisey J, Swagell CD, Hughes IP et al (2012) HapMap tag-SNP analysis confirms a role for COMT in schizophrenia risk and reveals a novel association. Eur Psychiatry 27:372–376